vimarsana.com
Home
Live Updates
ACTRIMS 2023: Most patients on Briumvi show no MS activity after 6 months | Briumvi led to no MS activity in 80% of patients in ULTIMATE trials : vimarsana.com
ACTRIMS 2023: Most patients on Briumvi show no MS activity after 6 months | Briumvi led to no MS activity in 80% of patients in ULTIMATE trials
More than 80% of MS patients on Briumvi in the ULTIMATE trials had no signs of disease activity after the first six months, data show.
Related Keywords
Colorado ,
United States ,
Sweden ,
California ,
San Diego ,
Washington ,
Swedish ,
Enrique Alvarez ,
Peiqing Qian ,
Swedish Neuroscience Institute ,
University Of Colorado ,
Americas Committee For Treatment ,
Research In Multiple Sclerosis ,
Americas Committee ,
Multiple Sclerosis ,
Disease Activity With Ublituximab ,
Participants With Relapsing Multiple Sclerosis ,
vimarsana.com © 2020. All Rights Reserved.